NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer treatment enters human testing
Disease control Not yet recruitingThis early-stage clinical trial is testing a new drug called SPGL008, both by itself and combined with an existing treatment (BCG), for people with high-risk non-muscle-invasive bladder cancer. The main goals are to find a safe dose and see if the treatment shows early signs of h…
Matched conditions: NMIBC
Phase: PHASE1, PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC
-
New hope for tough bladder cancers: trial tests combo therapy
Disease control Not yet recruitingThis study is for people with a high-risk form of bladder cancer that has returned after standard BCG immunotherapy. It will compare a new combination treatment (SHR-1501 plus BCG) against standard chemotherapy drugs chosen by the doctor. The goal is to see if the new combination…
Matched conditions: NMIBC
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New bladder cancer treatment aims to stop recurrence
Disease control Not yet recruitingThis study is testing whether adding a targeted drug called disitamab vedotin to the standard BCG treatment works better for controlling high-risk, early-stage bladder cancer. It will involve about 182 patients whose cancer has been surgically removed but is at high risk of retur…
Matched conditions: NMIBC
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC